LuminoDx
LuminoDx is a translational research organization providing end-to-end services from biomarker discovery to clinical test commercialization. The company leverages Olink proteomics, Biotechne ELLA ELISA, ELEMENT Bio's Aviti-24 sequencing, and its proprietary single-step microRNA analysis platform to support protein and molecular analysis workflows for biopharmaceutical development.
- Biotechnology
- Healthcare Technology
Funding
Founders
Founder details are not available yet.
Product
Problem
Biopharmaceutical companies and clinical researchers face significant bottlenecks in translating biomarker discoveries into validated clinical tests, requiring coordination across multiple specialized platforms and workflows. Fragmented service providers and complex multi-omics integration slow therapeutic development and delay the delivery of precision diagnostics to patients.
Solution
LuminoDx provides integrated translational research services that bridge discovery and clinical application through next-generation liquid biopsy and precision diagnostics. The company leverages Olink proteomics, Biotechne ELLA ELISA, ELEMENT Bio's Aviti-24 sequencing, and its proprietary single-step microRNA analysis platform to deliver biomarker discovery, assay development, and multi-omics profiling. Services span the full pipeline from early-stage biomarker identification through clinical validation and commercial test deployment, supporting both protein and molecular analysis workflows. LuminoDx also offers exosome isolation and advanced clinical testing, with a path to deliver tests through CLIA laboratories or as IVD products for domestic and global markets.
Target Audience
Primary customers are biopharmaceutical companies and clinical research organizations seeking translational research support for therapeutic development, as well as diagnostic developers needing biomarker discovery and clinical validation services.
Features
- Proprietary single-step microRNA analysis platform for streamlined molecular profiling
- Olink proteomics services for high-throughput protein biomarker discovery
- Biotechne ELLA ELISA system for automated, sensitive protein quantification
- ELEMENT Bio Aviti-24 sequencing and multi-omics platform for in-sample sequencing and spatial multi-omics
- End-to-end service model covering biomarker discovery, assay development and qualification, and clinical validation
- Exosome isolation capabilities for next-generation liquid biopsy applications
- CLIA laboratory and IVD product pathways for commercial test deployment